Cutera, Inc.
3240 Bayshore Boulevard
Brisbane
California
94005
United States
Tel: 415-657 5500
Fax: 415-330 2444
Website: http://www.cutera.com/
Email: info@cutera.com
245 articles about Cutera, Inc.
-
Cutera to Announce Fourth Quarter and Full-Year 2023 Results on March 21, 2024
3/1/2024
Cutera, Inc. today announced that it will report financial results for the fourth quarter and full year ended December 31, 2023 after the market close on Thursday, March 21, 2024.
-
Cutera, Inc. Announces Preliminary Unaudited Financial Results for Full-Year 2023
1/9/2024
Cutera, Inc., a leading provider of aesthetic and dermatology solutions, announced certain preliminary, unaudited financial results for the year ended December 31, 2023.
-
Cutera, Inc. Reports Inducement Grants as permitted by the Nasdaq Listing Rules - November 16, 2023
11/16/2023
Cutera, Inc., a leading provider of aesthetic and dermatology solutions, announced that Stephana Patton, who joined Cutera on November 13, 2023, as the Chief Legal Officer will receive a grant of inducement awards.
-
Cutera, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Annual Report on Form 10-Q
11/16/2023
Cutera, Inc. announced that it received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC on November 15, 2023 indicating that the Company is not currently in compliance with Nasdaq’s Listing Rules due to the Company’s inability to timely file its Form 10-Q for the period ended September 30, 2023 with the Securities and Exchange Commission.
-
Cutera, Inc. to Participate in Upcoming Investor Conferences - November 10, 2023
11/10/2023
Cutera, Inc. announced that Taylor Harris, Chief Executive Office, and Greg Barker, Vice President of Corporate FP&A and Investor Relations, will participate in Fireside Chats at the following upcoming investor conferences
-
Cutera Provides Third Quarter 2023 Business Update
11/8/2023
Cutera, Inc., a leading provider of aesthetic and dermatology solutions, provided preliminary financial results for the third quarter ended September 30, 2023, as well as recent business updates.
-
Cutera, Inc. to Announce Third Quarter Results on November 8, 2023
10/25/2023
Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the third quarter of 2023 after the market close on Wednesday, November 8, 2023.
-
Cutera Reports Inducement Grants as Permitted by the Nasdaq Listing Rules - October 06, 2023
10/6/2023
Cutera, Inc. announced that on October 3, 2023 the Compensation Committee of Cutera’s Board of Directors approved the grant of inducement awards to Brent Hauser, who joined Cutera on October 2, 2023, as the President, International.
-
Cutera, Inc. Appoints Brent Hauser as President, International
10/2/2023
Cutera, Inc. is pleased to announce the appointment of Brent Hauser as President, International, effective October 2, 2023.
-
Cutera Announces the Launch of New Skin Resurfacing and Revitalization Platform Secret DUO®
9/7/2023
CUTERA, INC. a global leader in aesthetic and dermatology solutions, announces the launch of Secret DUO, an innovative skin resurfacing and revitalization platform that utilizes dual non-ablative fractional technologies.
-
Cutera Reports Inducement Grants as permitted by the Nasdaq Listing Rules - September 01, 2023
9/1/2023
Cutera, Inc. announced that on August 17,2023 the Compensation Committee of Cutera’s Board of Directors approved the grant of inducement awards to Jeffrey Jones, who joined Cutera on August 28, 2023, as the Chief Operating Officer.
-
Cutera, Inc. Appoints Jeff Jones as Chief Operating Officer
8/24/2023
Cutera, Inc. is pleased to announce the appointment of Jeff Jones as Chief Operating Officer, effective August 28, 2023.
-
Cutera Announces Second Quarter 2023 Financial Results along with 2023 Outlook
8/8/2023
Cutera, Inc., a leading provider of aesthetic and dermatology solutions, reported financial results for the second quarter ended June 30, 2023.
-
Cutera, Inc. Appoints Taylor Harris as Chief Executive Officer
7/27/2023
CUTERA, INC. (“Cutera” or the “Company”) (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today announced that Taylor Harris has been appointed Chief Executive Officer, effective August 7, 2023.
-
Cutera, Inc. to Announce Second Quarter Results on August 8, 2023
7/21/2023
Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the second quarter of 2023 after the market close on Tuesday, August 8, 2023.
-
Cutera, Inc. to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on Tuesday, June 20th
6/19/2023
Cutera, Inc. has been invited to present at the Healthcare Virtual Conference Part II, presented by Maxim Group LLC and hosted by M-Vest, on Tuesday, June 20th at 9:00 a.m. ET.
-
FDA Clears AviClear® as a Long-Term Treatment for Mild to Severe Acne
6/15/2023
CUTERA, INC. a global leader in aesthetic and dermatology solutions, announces a new U.S. Food and Drug Administration Clearance of AviClear as a long-term treatment for mild to severe inflammatory acne vulgaris.
-
Cutera Cancels Special Meeting - May 15, 2023
5/15/2023
CUTERA, INC., a leading provider of aesthetic and dermatology solutions, announced that it has cancelled the Special Meeting of Stockholders previously scheduled for June 9, 2023.
-
Cutera Announces Agreements with Pura Vida and RTW
5/9/2023
CUTERA, INC., a leading provider of aesthetic and dermatology solutions, announced that it has entered into cooperation agreements with two of its largest stockholders, Pura Vida Investments, LLC and RTW Investments, LP, which collectively own more than 15% of the Company’s outstanding shares.
-
Cutera Announces First Quarter 2023 Financial Results
5/9/2023
Cutera, Inc., a leading provider of aesthetic and dermatology solutions, reported financial results for the first quarter ended March 31, 2023.